Department of Medicine

Sunil Kripalani named VP for Health System Sciences

NIH-funded trial to determine if immunomodulation can improve brain and cardiovascular dysfunction in Long COVID

Vanderbilt University Medical Center is working with scientists around the U.S. to launch the first Phase III, multicenter, placebo-controlled trial to determine the effect of immunomodulation on Long COVID.

VUMC mourns loss of renowned pulmonary medicine physician-scientist John H. Newman

John H. Newman, MD, an acclaimed physician-scientist in Vanderbilt University Medical Center’s Division of Allergy, Pulmonary and Critical Care Medicine who made numerous contributions to the knowledge of pulmonary vascular disease, died on Tuesday, Feb. 20, after a several-month illness. He was 78.

Large, diverse genetic study of glaucoma implicates vascular and cancer-related genes

An international genetic study using multiancestry biobanks has identified novel genetic locations associated with primary open-angle glaucoma, the most common type of glaucoma and the leading cause of irreversible blindness globally.

Liver disease specialist Ashley Spann receives two career development awards

Vanderbilt’s Ashley Spann, MD, MSACI, is the inaugural recipient of the Harold Amos Medical Faculty Development Program Hepatology Award from the American Association for the Study of Liver Diseases.

VUMC part of major step to achieving precision medicine

An analysis of genomic data from nearly 250,000 participants in the National Institutes of Health’s All of Us Research Program has identified more than 275 million previously unreported genetic variations, nearly 4 million of which have potential health consequences.

1 9 10 11 12 13 116